No Data
No Data
Eyenovia's Clobetasol Now Available in US After FDA Approval; Shares Rise Pre-Bell
Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery
Express News | Eyenovia Inc -on Sept 18, Got Notice From Nasdaq on Co's Failure to Satisfy a Continued Listing Rule or Standard
EYEN Shares Are Trading Higher Today: What You Need To Know
Eyenovia Shares Are Trading Higher After the Company Announced the Launch of a New FDA-Approved Ophthalmic Drug Along With Formosa Pharma.
Formosa Pharma and Eyenovia Set to Launch New FDA-Approved Ophthalmic Drug in US